CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis

Abstract excerpt

INTRODUCTION: Rheumatoid arthritis (RA), as one of the most disabling autoimmune diseases, is a common health problem that progressively reduces the life quality of patients. Although various biologics have been introduced for RA, attempts to establish an efficient long-term therapies failed due to the heterogeneity of this disease. METHODS: In the last decade, immunomodulatory approaches such as T cell adoptive...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CRISPR and Genetic Engineering
• Share to Monoclonal and Polyclonal Antibodies Research
• Share to T-cell and B-cell Immunology